ZA89552B - Pharmaceutical composition for 4-aroylimidazol-2-ones - Google Patents

Pharmaceutical composition for 4-aroylimidazol-2-ones

Info

Publication number
ZA89552B
ZA89552B ZA89552A ZA89552A ZA89552B ZA 89552 B ZA89552 B ZA 89552B ZA 89552 A ZA89552 A ZA 89552A ZA 89552 A ZA89552 A ZA 89552A ZA 89552 B ZA89552 B ZA 89552B
Authority
ZA
South Africa
Prior art keywords
aroylimidazol
ones
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA89552A
Other languages
English (en)
Inventor
Jack Domet
Domet Jack
Douglas W Danielson
W Danielson Douglas
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA89552B publication Critical patent/ZA89552B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA89552A 1988-01-29 1989-01-24 Pharmaceutical composition for 4-aroylimidazol-2-ones ZA89552B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14980388A 1988-01-29 1988-01-29

Publications (1)

Publication Number Publication Date
ZA89552B true ZA89552B (en) 1989-10-25

Family

ID=22531858

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89552A ZA89552B (en) 1988-01-29 1989-01-24 Pharmaceutical composition for 4-aroylimidazol-2-ones

Country Status (17)

Country Link
EP (1) EP0326103B1 (pt)
JP (1) JPH01226817A (pt)
KR (1) KR890011594A (pt)
CN (1) CN1035242A (pt)
AR (1) AR241632A1 (pt)
AT (1) ATE78161T1 (pt)
AU (1) AU611757B2 (pt)
DE (1) DE68902056T2 (pt)
DK (1) DK169566B1 (pt)
ES (1) ES2051898T3 (pt)
GR (1) GR3005792T3 (pt)
HU (1) HUT49282A (pt)
IE (1) IE62426B1 (pt)
IL (1) IL89049A0 (pt)
NZ (1) NZ227700A (pt)
PT (1) PT89561B (pt)
ZA (1) ZA89552B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2038744C (en) * 1990-03-23 2002-01-08 Yoshitomi Pharmaceutical Industries Ltd. Pharmaceutical composition containing slightly water-soluble drug
WO2005058280A2 (en) * 2003-12-12 2005-06-30 Myogen, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
WO2006007213A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
EP2581082B1 (de) 2011-10-10 2015-12-30 Carinopharm GmbH Pharmazeutische Zusammensetzung zur Behandlung von Status asthmaticus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405635A (en) * 1979-06-18 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Aroylimidazol-2-ones and their use as pharmaceuticals
EP0031603A1 (en) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmaceutical composition of matter
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
EP0326103B1 (en) 1992-07-15
DK37589D0 (da) 1989-01-27
NZ227700A (en) 1990-09-26
IE890275L (en) 1989-07-29
DK37589A (da) 1989-07-30
AU611757B2 (en) 1991-06-20
CN1035242A (zh) 1989-09-06
IE62426B1 (en) 1995-02-08
PT89561A (pt) 1989-10-04
HUT49282A (en) 1989-09-28
EP0326103A1 (en) 1989-08-02
GR3005792T3 (pt) 1993-06-07
DK169566B1 (da) 1994-12-05
DE68902056D1 (de) 1992-08-20
JPH01226817A (ja) 1989-09-11
ATE78161T1 (de) 1992-08-15
PT89561B (pt) 1994-01-31
KR890011594A (ko) 1989-08-21
ES2051898T3 (es) 1994-07-01
DE68902056T2 (de) 1992-12-03
AR241632A1 (es) 1992-10-30
IL89049A0 (en) 1989-08-15
AU2876889A (en) 1989-08-03

Similar Documents

Publication Publication Date Title
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
EP0403578A4 (en) Stable pharmaceutical composition
GB8825892D0 (en) Pharmaceutical composition
HU896876D0 (en) Pharmaceutical compositions
ZA893422B (en) Pharmaceutical composition
ZA89552B (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
ZA9017B (en) Pharmaceutical compositions
GB8827718D0 (en) Pharmaceutical composition
GB8809849D0 (en) Pharmaceutical composition
GB8818118D0 (en) Pharmaceutical composition
GB8807384D0 (en) Pharmaceutical composition
GB8806495D0 (en) Pharmaceutical composition
GB8802927D0 (en) Pharmaceutical composition
GB8818098D0 (en) Pharmaceutical composition
GB8802926D0 (en) Pharmaceutical composition
ZA893984B (en) Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
GB8822507D0 (en) Pharmaceutical compositions
GB8814146D0 (en) Pharmaceutical compositions
GB8809840D0 (en) Pharmaceutical compositions
GB8809650D0 (en) Pharmaceutical compositions
GB8815443D0 (en) Pharmaceutical compositions
ZA897139B (en) Pharmaceutical compositions
GB8809225D0 (en) Pharmaceutical compositions